1 study found for:    22906162 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents
Conditions: MDS;   Myelodysplastic Syndromes;   Thrombocytopenia
Interventions: Drug: Placebo;   Biological: AMG 531 (Romiplostim);   Drug: Azacitidine;   Drug: Decitabine

Indicates status has not been verified in more than two years